• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Avian Pathol . dentification of catalytically active domain epitopes in neuraminidase protein of H9N2 subtype of avian influenza virus

tetano

Editor, Senior Moderator
Avian Pathol


. 2023 Aug 15;1-11.
doi: 10.1080/03079457.2023.2239191. Online ahead of print. Identification of catalytically active domain epitopes in neuraminidase protein of H9N2 subtype of avian influenza virus

Xiangyu Huang[SUP] 1 2 [/SUP], Yiqin Cai[SUP] 1 2 [/SUP], Guihu Yin[SUP] 1 2 [/SUP], Zili Chen[SUP] 3 [/SUP], Jianing Hu[SUP] 1 2 [/SUP], Zichen Gao[SUP] 1 2 [/SUP], Xinyu Guo[SUP] 1 2 [/SUP], Fuqiang Xiong[SUP] 1 2 [/SUP], Xiuli Feng[SUP] 1 2 [/SUP]



Affiliations
Abstract

H9N2 subtype of avian influenza virus (AIV) is primarily a bird virus, which is widespread in clinical avian disease, and reported in cases of human infection. As one of the surface proteins of AIV, the neuraminidase (NA) protein plays an important role mainly in viral budding. However, vaccine development and detection methods for NA of H9N2 AIVs are in urgent clinical need. In this study, a truncated NA gene (205-900 bp) was cloned from the NA sequence of H9N2 strain, and then expressed using pET-28a (+) vector. This purified recombinant NA protein was used to immunize BALB/c mice, and the monoclonal antibodies were screened through the indirect enzyme-linked immunosorbent assay (ELISA). Next, eight prokaryotic expression vectors were constructed for epitope identification. After cell fusion, three hybridoma cell lines producing the antibodies special to NA protein were screened by ELISA, western blotting, and indirect immunofluorescence; these were named 1B10, 2B6, and 5B2, respectively. Epitope scanning techniques were used to identify three B-cell epitopes recognized by these three monoclonal antibodies, [SUP]196[/SUP]KNATASIIYDGMLVD[SUP]210[/SUP], [SUP]210[/SUP]DSIGSWSKNIL[SUP]220[/SUP] and [SUP]221[/SUP]RTQESECVCI[SUP]230[/SUP]. The subsequent homology analysis revealed the three epitopes were highly conserved in H9N2 AIV strains. The structural predictions of the antigenic epitopes indicated that all three epitopes were located in the catalytic region of NA. These results provide a basis for studying the function of the NA protein of H9N2 AIV and technical support for the development of a universal detection method based on anti-NA monoclonal antibodies.

Keywords: H9N2 avian influenza virus; NA protein; antigen epitope; catalytically active domain; epitope scanning technique; monoclonal antibody.

 
Back
Top Bottom